Leadercare
CLOSE X

Tata India Pharma & Healthcare Fund-Reg(G)

As on May-16-2022 change fund
15.67  up0.01 (0.08%)

fund objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2017-20182018-20192019-20202020-20212021-2022
NAV in Rs (as on 31-Mar-2022)8.359.098.9314.7317.18
Net Assets(Rs Crores) (as on 31-Mar-2022) 133.13 179.56 152.64 435.03 553.33
Scheme Returns(%)(Absolute)-9.687.51-2.1967.2416.04
B'mark Returns(%)(Absolute)-20.438.42-23.4574.669.75
Category Rank54/6224/7311/7549/7541/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2021-202216.843.710.97-4.64
2020-202125.0721.7811.24-2.68
2019-2020-4.661.784.39-2.98
2018-20192.446.80-4.444.15
2017-2018-4.38-6.159.58-6.86
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...14.95 
Dr. Reddy's Laboratories Ltd.10.03 
Cipla Ltd.9.38 
Apollo Hospitals Enterprise Ltd.6.97 
Alkem Laboratories Ltd.6.22 
Ipca Laboratories Ltd.5.96 
Fortis Healthcare Ltd.4.99 
Lupin Ltd.4.47 
JB Chemicals & Pharmaceuticals...3.29 
Aurobindo Pharma Ltd.2.98 

Category

Sector Funds

Launch Date

28-Dec-15

ISIN Code

INF277K016A9

Scheme Benchmark

NA

AUM ( in Cr.)

538.47

portfolio price to book value

5.53

investing style?

Large Growth

fund manager?

Meeta Shetty

inception date (regular plan)

28-Dec-15

expense ratio (regular plan) %

2.50

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs73.93
Hospital & Healthcare Services17.01
Miscellaneous2.98
Insurance0.48

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015538.47-3.9621.6311.31NA7.28
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,789.63-2.2426.50NANA20.27
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,270.01-3.2326.48NANA22.20
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,851.32-6.6023.2215.3216.9320.08
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20182,391.65-7.4623.22NANA16.72
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005766.09-8.2521.3510.6113.5317.20
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,763.30-8.0221.279.3615.3014.90
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201967.07-8.2819.40NANA17.13
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019506.02-7.29NANANA19.62
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021174.80NANANANA-11.68
ENTRY LOAD / EXIT LOAD
Max Entry Load [%]
0.00
Entry Remark
Max Exit Load [%]
0.25
Exit Remark
0.25% on or before 30D
52 Week Highs & Lows
52 Week High
18.34
52 Week Low
15.49
portfolio characteristics
As on 30-Apr-2022
Average Maturity
N.A
Modified Duration
N.A
Yield to Maturity
N.A.
Portfolio Turnover Ratio
37.27 Times
ratios
Statistical Ratios
Standard Deviation [%]
17.0550
Semi Standard Deviation [%]
0.6402
Beta [%]
0.5087
Sharp Ratio [%]
-0.1685
R-Square [%]
0.5790
Expense Ratio [%]
2.5000
AVG Ratio [%]
0.0368
Other Ratios
Jenson Ratio [%]
-0.0364
Treynor Ratio [%]
-0.0458
Turnover Ratio [%]
37.2700
FAMA Ratio [%]
-0.0374
SORTINO Ratio [%]
0.0404
HEAD OFFICE Leader Care A-507/8 Navratna Corporate Park, Ashok Vatika Bopal-Ambli Road, Ahmedabad-380058
DISCLAIMER

Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objective of the Scheme will be achieved. Past performance of the Sponsor/AMC/Fund or that of any scheme of the Fund does not indicate the future performance of the Schemes of the Fund. Please read the Key Information Memorandum and the Offer Document carefully before investing.

  • INSURANCE DISCLAIMER - Insurance is a subject matter of solicitation
  • ARN Number - 11439
  • IRDAI Licence Number - AGQ0127782

Copyright © 2019Leader CareAll rights reserved

Designed, Developed & Content Powered by Accord Fintech Pvt. Ltd.